Xcout Intel
ROCHE I
Roche is a healthcare company that develops and provides pharmaceuticals and diagnostic solutions. It focuses on preventing, diagnosing, and treating severe health conditions such as cancer, cardiovascular-metabolic diseases, and neurological disorders for patients worldwide.
Subscribe to see ROCHE I’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ROCHE I at a glance
ROCHE I is a pharmaceuticals company. Xcout tracks 23 named people at ROCHE I, including Dr Thomas Schinecker (Chief Executive Officer Roche Group).
ROCHE I leadership
- Dr Thomas SchineckerChief Executive Officer Roche Group
- Matt SauseCEO Roche Diagnostics
- Teresa GrahamCEO Roche Pharmaceuticals
- Dr Alan HippeChief Financial Officer
- Cristina A. WilburChief People Officer
- Dr Levi GarrawayHead of Global Product Development and Chief Medical Officer
17 more named people on record for ROCHE I, with roles, board committees and tenure — see the full roster →
ROCHE I competitors
A few of ROCHE I's closest competitors — see the full list of competitors and alternatives →
Roche Singapore Pte Ltd researches and develops pharmaceuticals and diagnostic solutions to detect, treat, and monitor various diseases. The company utilizes data-based insights to support healthcare professionals and improve patient health outcomes.
Roche Polska develops and provides pharmaceutical products, diagnostic solutions, and digital health tools. The company serves patients, healthcare professionals, and medical institutions by advancing medical research and personalized healthcare.
Roche (Hungary) Ltd. is a Hungarian entity of Roche, involved in pharmaceuticals, diagnostics, and diabetes care. Its offices are located in Budapest and Budaörs, Hungary.
Roche (Thailand) Ltd. is a subsidiary of F. Hoffmann-La Roche Ltd. The company has marked its 50th anniversary in Thailand, focusing on advancing science and medical access to improve the quality of life.
Roche S.p.A. is a company with its registered office located in Monza, Italy. The evidence indicates it is part of the larger Roche group.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a comprehensive healthcare enterprise, operating across Mainland China and international markets. Its principal activities include the research, development, production, and commercialization of pharmaceutical products. The company focuses on significant therapeutic domains such as oncology, immunology, metabolic disorders, gastrointestinal health, and central nervous system conditions. In addition to its drug offerings, Fosun Pharma provides medical devices and diagnostic solutions. Its multifaceted operations are organized into five key segments: pharmaceutical manufacturing, medical devices and diagnostics, healthcare services, pharmaceutical distribution and retail, and other business initiatives. This scope extends to managing healthcare facilities and hospitals, as well as the wholesale and retail distribution of medicines. The company was founded in 1994 and is headquartered in Shanghai, China.
Get ROCHE I's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ROCHE I in Xcout Intel
- 23 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access